| Product Code: ETC7656990 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neuroprotective Products Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neuroprotective Products Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neuroprotective Products Market - Industry Life Cycle |
3.4 Israel Neuroprotective Products Market - Porter's Five Forces |
3.5 Israel Neuroprotective Products Market Revenues & Volume Share, By Class of Drugs, 2021 & 2031F |
3.6 Israel Neuroprotective Products Market Revenues & Volume Share, By Use in the treatment of Medical Conditions, 2021 & 2031F |
4 Israel Neuroprotective Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Israel |
4.2.2 Growing awareness about the importance of neuroprotection in healthcare |
4.2.3 Technological advancements in neuroprotective products |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for neuroprotective products in Israel |
4.3.2 High costs associated with neuroprotective treatments and products |
4.3.3 Limited availability of neuroprotective products in the market |
5 Israel Neuroprotective Products Market Trends |
6 Israel Neuroprotective Products Market, By Types |
6.1 Israel Neuroprotective Products Market, By Class of Drugs |
6.1.1 Overview and Analysis |
6.1.2 Israel Neuroprotective Products Market Revenues & Volume, By Class of Drugs, 2021- 2031F |
6.1.3 Israel Neuroprotective Products Market Revenues & Volume, By Cholinesterase inhibitors, 2021- 2031F |
6.1.4 Israel Neuroprotective Products Market Revenues & Volume, By NMDA receptor antagonists, 2021- 2031F |
6.1.5 Israel Neuroprotective Products Market Revenues & Volume, By Anti-inflammatory and anti-apoptotic agents, 2021- 2031F |
6.1.6 Israel Neuroprotective Products Market Revenues & Volume, By Neurotropic factors, 2021- 2031F |
6.1.7 Israel Neuroprotective Products Market Revenues & Volume, By Mitochondrial dysfunction regulators, 2021- 2031F |
6.1.8 Israel Neuroprotective Products Market Revenues & Volume, By Metal Ion Chelators, 2021- 2031F |
6.1.9 Israel Neuroprotective Products Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Israel Neuroprotective Products Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Neuroprotective Products Market, By Use in the treatment of Medical Conditions |
6.2.1 Overview and Analysis |
6.2.2 Israel Neuroprotective Products Market Revenues & Volume, By Alzheimer's disease, 2021- 2031F |
6.2.3 Israel Neuroprotective Products Market Revenues & Volume, By Multiple sclerosis, 2021- 2031F |
6.2.4 Israel Neuroprotective Products Market Revenues & Volume, By Parkinson's disease, 2021- 2031F |
6.2.5 Israel Neuroprotective Products Market Revenues & Volume, By Ocular degeneration (retinal disorders), 2021- 2031F |
6.2.6 Israel Neuroprotective Products Market Revenues & Volume, By Amyotrophic lateral sclerosis (ALS), 2021- 2031F |
6.2.7 Israel Neuroprotective Products Market Revenues & Volume, By Huntington's disease, 2021- 2031F |
6.2.8 Israel Neuroprotective Products Market Revenues & Volume, By Other disorders affecting the nervous system., 2021- 2031F |
6.2.9 Israel Neuroprotective Products Market Revenues & Volume, By Other disorders affecting the nervous system., 2021- 2031F |
7 Israel Neuroprotective Products Market Import-Export Trade Statistics |
7.1 Israel Neuroprotective Products Market Export to Major Countries |
7.2 Israel Neuroprotective Products Market Imports from Major Countries |
8 Israel Neuroprotective Products Market Key Performance Indicators |
8.1 Research and development investment in neuroprotective products |
8.2 Adoption rate of neuroprotective products by healthcare providers in Israel |
8.3 Number of clinical trials and studies conducted on neuroprotective products in Israel. |
9 Israel Neuroprotective Products Market - Opportunity Assessment |
9.1 Israel Neuroprotective Products Market Opportunity Assessment, By Class of Drugs, 2021 & 2031F |
9.2 Israel Neuroprotective Products Market Opportunity Assessment, By Use in the treatment of Medical Conditions, 2021 & 2031F |
10 Israel Neuroprotective Products Market - Competitive Landscape |
10.1 Israel Neuroprotective Products Market Revenue Share, By Companies, 2024 |
10.2 Israel Neuroprotective Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here